Formulations of ag10
AssigneeEidos Therapeutics, Inc.
InventorsJesper JERNELIUS, Mark Michael MENNING
Life of this patent
Estimating the term…
Abstract
The present disclosure provides high-load tablet formulations of AG10 or a pharmaceutically acceptable salt thereof. In some aspects, provided herein are table formulations of AG10 or a pharmaceutically acceptable salt thereof that include at least 40% or more AG10 by weight and at least one pharmaceutical excipient selected from one or more fillers, one or more binders, one or more disintegrants, and one or more lubricants.
Claims31
A tablet formulation comprising AG10 or a pharmaceutically acceptable salt thereof and at least one pharmaceutical excipient selected from one or more fillers, one or more binders, one or more disintegrants, and one or more lubricants, wherein
- said tablet comprises at least 40% or more by weight of AG10 or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.